Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics, safety, and efficacy of WR 279,396 (paromomycin + gentamicin topical cream) and paromomycin topical cream for cutaneo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Paromomycin Topical Cream (Paromomycin topical cream)
• WR 279,396

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Leishmaniasis, Cutaneous | Phase 2 | Status: COMPLETED | Results posted: 2014-05-15